Total Long Term Debt (Quarterly) Chart

View Total Long Term Debt (Quarterly) for NCNA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Long Term Debt (Quarterly) Chart
Start Trial

Historical Total Long Term Debt (Quarterly) Data

View and export this data back to 2018. Start Trial.
Date Value
June 30, 2026 0.892M
March 31, 2026 0.8967M
December 31, 2025 0.9093M
September 30, 2025 0.1831M
June 30, 2025 0.2111M
March 31, 2025 0.2233M
December 31, 2024 0.2379M
September 30, 2024 0.2964M
June 30, 2024 0.3552M
March 31, 2024 0.4283M
December 31, 2023 0.5048M
September 30, 2023 0.5517M
June 30, 2023 0.7183M
March 31, 2023 0.7443M
December 31, 2022 0.7686M
September 30, 2022 0.7613M
June 30, 2022 0.2866M
Date Value
March 31, 2022 0.3949M
December 31, 2021 0.5025M
September 30, 2021 0.5905M
June 30, 2021 0.699M
March 31, 2021 0.7947M
December 31, 2020 0.8817M
September 30, 2020 0.9295M
June 30, 2020 0.8341M
March 31, 2020 0.9213M
December 31, 2019 1.068M
September 30, 2019 0.5385M
June 30, 2019 0.6109M
March 31, 2019 0.6893M
December 31, 2018 0.00
September 30, 2018 0.00
June 30, 2018 0.00
March 31, 2018 0.00

Total Long Term Debt Definition

Represents a company's total debt maturing for more than 12 months of the reporting period.

Read full definition.

Total Long Term Debt (Quarterly) Range, Past 5 Years

View Total Long Term Debt (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Long Term Debt (Quarterly) Benchmarks

View Total Long Term Debt (Quarterly) Benchmarks
Start Trial
Biodexa Pharmaceuticals Plc 0.00
Mereo BioPharma Group Plc 0.00
BioNTech SE 349.05M
Silence Therapeutics Plc 0.009M
Autolus Therapeutics Plc 362.02M